Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of 0.84 is 111% above its 5-year average of -7.53, near the high end of its 5-year range (-47.20–1.22).
95.35% above its 12-month average of 0.43.
Reported quarterly EPS; no daily interpolation. Q1 FY2027 (2026-06-30): 0.50.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T18:37:39.179Z. Historical observations retain their original dates. Historical series through 2026-10-05.
EARNINGS PER SHARE (EPS)
0.84
EARNINGS PER SHARE (EPS) AVG TTM
0.43
EARNINGS PER SHARE (EPS) AVG 3Y
-11.54
EARNINGS PER SHARE (EPS) AVG 5Y
-7.53
EARNINGS PER SHARE (EPS) AVG 10Y
-3.41
EARNINGS PER SHARE (EPS) AVG 15Y
1.46
EARNINGS PER SHARE (EPS) AVG 20Y
1.42
CURRENT VS TTM AVG
+95.35%
CURRENT VS 3Y AVG
+107.28%
CURRENT VS 5Y AVG
+111.16%
CURRENT VS 10Y AVG
+124.62%
CURRENT VS 15Y AVG
-42.31%
CURRENT VS 20Y AVG
-41.03%
Mesa Laboratories, Inc.
Market Cap
$759.00M
Earnings Per Share (EPS)
0.84
TTM Avg
0.43
3Y Avg
-11.54
5Y Avg
-7.53
Market Cap
$764.86M
Earnings Per Share (EPS)
N/A
TTM Avg
-1.23
3Y Avg
-1.23
5Y Avg
-1.23
Market Cap
$747.65M
Earnings Per Share (EPS)
-1.18
TTM Avg
-1.05
3Y Avg
-1.11
5Y Avg
-0.92
Market Cap
$774.23M
Earnings Per Share (EPS)
-0.15
TTM Avg
-0.39
3Y Avg
-0.55
5Y Avg
-0.57
Market Cap
$778.22M
Earnings Per Share (EPS)
0.52
TTM Avg
-1.70
3Y Avg
-0.56
5Y Avg
-0.09
Market Cap
$783.39M
Earnings Per Share (EPS)
-0.75
TTM Avg
-1.06
3Y Avg
-1.25
5Y Avg
-1.46
Market Cap
$786.76M
Earnings Per Share (EPS)
-0.10
TTM Avg
-0.20
3Y Avg
-0.27
5Y Avg
-0.29
Market Cap
$733.02M
Earnings Per Share (EPS)
-1.41
TTM Avg
-1.23
3Y Avg
-0.97
5Y Avg
-1.16
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Mesa Laboratories, Inc. (MLAB) | $759.00M | 0.84 | 0.43 | -11.54 | -7.53 |
| Attovia Therapeutics, Inc. (ATTO)vs › | $764.86M | N/A | -1.23 | -1.23 | -1.23 |
| Design Therapeutics, Inc. (DSGN)vs › | $747.65M | -1.18 | -1.05 | -1.11 | -0.92 |
| Apnimed, Inc. (APMD)vs › | $744.71M | N/A | N/A | N/A | N/A |
| Lexicon Pharmaceuticals, Inc. (LXRX)vs › | $774.23M | -0.15 | -0.39 | -0.55 | -0.57 |
| Varex Imaging Corporation (VREX)vs › | $778.22M | 0.52 | -1.70 | -0.56 | -0.09 |
| Sana Biotechnology, Inc. (SANA)vs › | $783.39M | -0.75 | -1.06 | -1.25 | -1.46 |
| Geron Corporation (GERN)vs › | $786.76M | -0.10 | -0.20 | -0.27 | -0.29 |
| Candel Therapeutics, Inc. (CADL)vs › | $733.02M | -1.41 | -1.23 | -0.97 | -1.16 |
| Achieve Life Sciences, Inc. (ACHV)vs › | $732.96M | -1.55 | -1.25 | -1.99 | -2.90 |
Trailing EPS (TTM)
$0.84
Forward EPS (Est.)
$10.19
P/E Ratio
161.5
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2026-03-31 | 1.22 |
| 2025-03-31 | -0.36 |
| 2024-03-31 | -47.20 |
| 2023-03-31 | 0.17 |
| 2022-03-31 | 0.36 |
| 2021-03-31 | 0.66 |
| 2020-03-31 | 0.32 |
| 2019-03-31 | 1.95 |
| 2018-03-31 | -0.79 |
| 2017-03-31 | 3.04 |
| 2016-03-31 | 3.10 |
| 2015-03-31 | 2.72 |
| 2014-03-31 | 2.61 |
| 2013-03-31 | 2.52 |
| 2012-03-31 | 2.41 |
| 2011-03-31 | 1.91 |
| 2010-03-31 | 1.49 |
| 2009-03-31 | 1.51 |
| 2008-03-31 | 1.46 |
| 2007-03-31 | 1.25 |
| 2006-03-31 | 0.94 |
| 2005-03-31 | 0.76 |
| 2004-03-31 | 0.70 |
| 2003-03-31 | 0.66 |
| 2002-03-31 | 0.60 |
| 2001-03-31 | 0.59 |
| 2000-03-31 | 0.55 |
| 1999-03-31 | 0.51 |
| 1998-03-31 | 0.48 |
| 1997-03-31 | 0.39 |
(FMP quote price / unrounded diluted TTM EPS) / five-year diluted EPS CAGR in percent, from annual statements through the period end shown Quote observation: 2026-10-06T18:37:39.179Z. Historical observations retain their original dates. Historical series through 2026-10-05.
